Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px
Organisation › Details

Adcendo ApS

Adcendo ApS, a spin-out from the University of Copenhagen and Rigshospitalet and previously part of the BioInnovation Institute’s Creation House Program, is developing novel antibody-drug conjugates (ADCs) for treatment of cancers. It was founded in 2017 by scientists Niels Behrendt, Lars Henning Engelholm and Christoffer Nielsen from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen, and Henrik Stage, a biotech-entrepreneur active in several biotech companies, and previously CEO/CFO of Santaris Pharma which was acquired by Roche in 2014. In 2018, Adcendo was awarded a pre-seed grant from the Novo Nordisk Foundation, the owner of Novo Holdings, to help the company develop the commercial potential of its research discovery. The scientific advisory board includes John Lambert PhD, the former CSO of ImmunoGen, Vincent de Groot PhD, Founder of the ADC company Syntarga, and Murray Yule MD, PhD, Oncologist experienced in translational oncology including ADCs. *


Period Start 2017-01-01 established (s-off)
  Predecessor University of Copenhagen
Product Industry  oncology
Persons Person Pehl, Michael (Adcendo 202107– CEO before Gemoab + Immunomedics + Celgene + Amgen)
  Person 2 Stage, Henrik (Adcendo 202107– CFO before CEO formerly Santaris Pharma 201401 CFO)
Region Region København (Copenhagen)
  Country Denmark
  Street 3 Ole Maaløes Vej
BioInnovation Institute (BII)
  City 2200 København
    Address record changed: 2020-12-02
Basic data Employees A: 1 to 10 (2019-12-24)
    * Document for »About Section«: Adcendo ApS. (4/29/21). "Press Release: Adcendo Raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers". Copenhagen.
Record changed: 2023-07-10


Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x200px

More documents for Adcendo ApS

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x300px

» top